Literature DB >> 22513002

Malformations of cortical development and epilepsy in adult patients.

C E Papayannis1, D Consalvo, M A Kauffman, G Seifer, S Oddo, L D'Alessio, P Saidon, S Kochen.   

Abstract

OBJECTIVE: To describe clinical features of epilepsy secondary to Malformation of Cortical Development (MCD) in a series of adult patients.
MATERIALS AND METHODS: We searched our database for all cases with confirmed epilepsy and MCD and included in the study only those with complete data. Mean age, sex, age at seizure onset (ASO), seizure types, abnormal neurological exam (ANE), mental retardation, family history, gestational or perinatal insults (G-PI), interictal EEG and response to treatment were analyzed. Cases were classified into the 3 main groups (G) according to the Barkovich classification (BC) and then compared: (G1) "malformations due to abnormal cell proliferation", (G2) "malformations due to abnormal migration" and (G3) "malformations due to abnormal cortical organization".
RESULTS: We identified 152 (5.06%) patients with MCD from a total of 3000 with epilepsy. In total, 138 patients with complete medical data were included in this study. The mean age of patients was 36.2 years, 52.2% were female, the mean ASO was 12.3 years, 5.1% of cases had a positive family history and 21% had G-PI. An ANE was observed in 21% and mental retardation in 31.9%. Most of the patients (84.8%) had refractory epilepsy. The distribution of cases according to the BC was: 51.4% in G1, 28.9% in G2 and 19.6% in G3. Comparing the 3 groups, we found that an ANE was statistically more frequent in G3 and was present in 70.4% of cases.
CONCLUSION: Our series of adult patients with epilepsy and MCD suggests that MCD are identified as commonly in a developing country as in previous "first world" series. Neurological deficits were more common in the subgroup of patients with polymicrogyria and schizencephaly (BC Group 3).
Copyright © 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22513002     DOI: 10.1016/j.seizure.2012.03.009

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  6 in total

Review 1.  Precision Therapy for Epilepsy Related to Brain Malformations.

Authors:  Alissa M D'Gama; Annapurna Poduri
Journal:  Neurotherapeutics       Date:  2021-10-04       Impact factor: 6.088

2.  Upregulation of RBFOX1 in the malformed cortex of patients with intractable epilepsy and in cultured rat neurons.

Authors:  Ming Wen; Yong Yan; Ning Yan; Xiao Shan Chen; Shi Yong Liu; Zhan Hui Feng
Journal:  Int J Mol Med       Date:  2015-01-05       Impact factor: 4.101

Review 3.  Computational analysis in epilepsy neuroimaging: A survey of features and methods.

Authors:  Lohith G Kini; James C Gee; Brian Litt
Journal:  Neuroimage Clin       Date:  2016-02-23       Impact factor: 4.881

4.  Human mutations in integrator complex subunits link transcriptome integrity to brain development.

Authors:  Renske Oegema; David Baillat; Rachel Schot; Leontine M van Unen; Alice Brooks; Sima Kheradmand Kia; A Jeannette M Hoogeboom; Zheng Xia; Wei Li; Matteo Cesaroni; Maarten H Lequin; Marjon van Slegtenhorst; William B Dobyns; Irenaeus F M de Coo; Frans W Verheijen; Andreas Kremer; Peter J van der Spek; Daphne Heijsman; Eric J Wagner; Maarten Fornerod; Grazia M S Mancini
Journal:  PLoS Genet       Date:  2017-05-25       Impact factor: 5.917

5.  Modeling Neurodevelopmental Disorders and Epilepsy Caused by Loss of Function of kif2a in Zebrafish.

Authors:  Michèle Partoens; Ann-Sofie De Meulemeester; Hoi-Khoanh Giong; Duc-Hung Pham; Jeong-Soo Lee; Peter A de Witte; Aleksandra Siekierska
Journal:  eNeuro       Date:  2021-09-07

6.  Neurodevelopmental Findings and Epilepsy in Malformations of Cortical Development.

Authors:  Olcay Şah; Dilşad Türkdoğan; Selda Küçük; Gülnur Takış; Ruslan Asadov; Gülten Öztürk; Olcay Ünver; Gazanfer Ekinci
Journal:  Turk Arch Pediatr       Date:  2021-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.